13F HOLDINGS REPORT
GREAT POINT PARTNERS LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001172661-23-004025
Total Value
$549.0M
Positions
42
Other Managers
2
Confidential Omitted
No
Holdings (42)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | UROGEN PHARMA LTD | URGN | 2,620,545 | $36.7M | 6.69% |
| 2 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 3,078,633 | $35.3M | 6.42% |
| 3 | PLIANT THERAPEUTICS INC | PLRX | 1,755,184 | $30.4M | 5.54% |
| 4 | VAXCYTE INC | PCVX | 531,211 | $27.1M | 4.93% |
| 5 | ULTRAGENYX PHARMACEUTICAL IN | RARE | 727,426 | $25.9M | 4.72% |
| 6 | ALKERMES PLC | ALKS | 875,044 | $24.5M | 4.46% |
| 7 | RAPT THERAPEUTICS INC | 75382E109 | 1,458,070 | $24.2M | 4.41% |
| 8 | ZURA BIO LTD | ZURA | 3,295,000 | $21.7M | 3.96% |
| 9 | SAREPTA THERAPEUTICS INC | SRPT | 165,200 | $20.0M | 3.65% |
| 10 | EVOLUS INC | EOLS | 2,186,934 | $20.0M | 3.64% |
| 11 | POINT BIOPHARMA GLOBAL INC | 730541109 | 2,909,960 | $19.4M | 3.54% |
| 12 | CYTOKINETICS INC | CYTK | 600,000 | $17.7M | 3.22% |
| 13 | XENON PHARMACEUTICALS INC | XENE | 500,001 | $17.1M | 3.11% |
| 14 | ANAPTYSBIO INC | ANABV | 894,333 | $16.1M | 2.93% |
| 15 | IMMUNOCORE HLDGS PLC | IMCR | 290,917 | $15.1M | 2.75% |
| 16 | AEROVATE THERAPEUTICS INC | 008064107 | 1,091,233 | $14.8M | 2.70% |
| 17 | INTRA-CELLULAR THERAPIES INC | 46116X101 | 225,000 | $11.7M | 2.13% |
| 18 | ACLARIS THERAPEUTICS INC | ACRS | 1,691,768 | $11.6M | 2.11% |
| 19 | SAREPTA THERAPEUTICS INC | SRPT | 95,000 | $11.5M | 2.10% |
| 20 | PTC THERAPEUTICS INC | PTCT | 500,000 | $11.2M | 2.04% |
| 21 | REPLIMUNE GROUP INC | REPL | 638,495 | $10.9M | 1.99% |
| 22 | OPTINOSE INC | 68404V100 | 8,839,939 | $10.9M | 1.98% |
| 23 | AMICUS THERAPEUTICS INC | FOLD | 857,000 | $10.4M | 1.90% |
| 24 | ARCELLX INC | ACLX | 287,500 | $10.3M | 1.88% |
| 25 | KARUNA THERAPEUTICS INC | 48576A100 | 60,500 | $10.2M | 1.86% |
| 26 | AKERO THERAPEUTICS INC | 00973Y108 | 198,500 | $10.0M | 1.83% |
| 27 | INSMED INC | INSM | 394,872 | $10.0M | 1.82% |
| 28 | RENEO PHARMACEUTICALS INC | 75974E103 | 1,167,061 | $8.9M | 1.62% |
| 29 | APOGEE THERAPEUTICS INC | APGE | 400,000 | $8.5M | 1.55% |
| 30 | GOSSAMER BIO INC | GOSS | 6,230,272 | $5.2M | 0.95% |
| 31 | IGM BIOSCIENCES INC | 449585108 | 615,317 | $5.1M | 0.94% |
| 32 | HERON THERAPEUTICS INC | HRTX | 4,737,368 | $4.9M | 0.89% |
| 33 | ACLARIS THERAPEUTICS INC | ACRS | 700,000 | $4.8M | 0.87% |
| 34 | CEREVEL THERAPEUTICS HLDNG I | 15678U128 | 215,000 | $4.7M | 0.85% |
| 35 | ACUMEN PHARMACEUTICALS INC | ABOS | 1,074,101 | $4.5M | 0.81% |
| 36 | GENERATION BIO CO | 37148K100 | 1,022,537 | $3.9M | 0.71% |
| 37 | MIRATI THERAPEUTICS INC | 60468T105 | 86,302 | $3.8M | 0.68% |
| 38 | TERNS PHARMACEUTICALS INC | TERN | 645,899 | $3.2M | 0.59% |
| 39 | TALARIS THERAPEUTICS INC | 87410C104 | 1,000,000 | $2.8M | 0.51% |
| 40 | GRACELL BIOTECHNOLOGIES INC | 38406L103 | 579,667 | $1.7M | 0.30% |
| 41 | SOLID BIOSCIENCES INC | SLDB | 450,403 | $1.1M | 0.21% |
| 42 | AMBRX BIOPHARMA INC | 02290A102 | 97,700 | $1.1M | 0.20% |